FDA decides to revoke Avastin for breast cancer - Penn State Hershey Cancer Institute

http://pennstatehershey.org/cancer The U.S. Food and Drug Administration has withdrawn its approval of Avastin, a drug commonly used in patients with advanced breast cancer. Dr. Leah Cream, an assistant professor of medicine at Penn State Hershey Cancer Institute, gives her reaction to the decision and explains its significance for breast cancer patients and their doctors.

Category:

Science & Technology

Tags:

• penn state
• penn state hershey
• cancer institute
• breast cancer
• Avastin
• FDA
• Cancer
• Food And Drug Administration